Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes: proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
St. Louis, MO
Mosby
1999
|
| Schriftenreihe: | American heart journal
138,4,2 = Suppl. |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zeitschr.-Suppl. |
| Beschreibung: | 2 S., S. 262 - 326 Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV012856202 | ||
| 003 | DE-604 | ||
| 005 | 20220222 | ||
| 007 | t | ||
| 008 | 991112s1999 ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)45434919 | ||
| 035 | |a (DE-599)BVBBV012856202 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-12 | ||
| 245 | 1 | 0 | |a Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes |b proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia |c guest ed.: James E. Tcheng ... |
| 264 | 1 | |a St. Louis, MO |b Mosby |c 1999 | |
| 300 | |a 2 S., S. 262 - 326 |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a American heart journal |v 138,4,2 = Suppl. | |
| 500 | |a Einzelaufnahme eines Zeitschr.-Suppl. | ||
| 650 | 0 | 7 | |a Thrombozytenmembran |0 (DE-588)4416233-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Ischämie |0 (DE-588)4162456-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Thrombozytenaggregationshemmer |0 (DE-588)4059968-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antigen CD41 |0 (DE-588)4604678-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Herzkrankheit |0 (DE-588)4024663-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 31.03.1998 |z Atlanta, Ga. |2 gnd-content | |
| 689 | 0 | 0 | |a Herzkrankheit |0 (DE-588)4024663-2 |D s |
| 689 | 0 | 1 | |a Ischämie |0 (DE-588)4162456-7 |D s |
| 689 | 0 | 2 | |a Thrombozytenaggregationshemmer |0 (DE-588)4059968-1 |D s |
| 689 | 0 | 3 | |a Thrombozytenmembran |0 (DE-588)4416233-9 |D s |
| 689 | 0 | 4 | |a Antigen CD41 |0 (DE-588)4604678-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Tcheng, James E. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008747739 | ||
Datensatz im Suchindex
| _version_ | 1804127535785574400 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV012856202 |
| ctrlnum | (OCoLC)45434919 (DE-599)BVBBV012856202 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01689nam a2200409 cb4500</leader><controlfield tag="001">BV012856202</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20220222 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">991112s1999 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)45434919</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012856202</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes</subfield><subfield code="b">proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia</subfield><subfield code="c">guest ed.: James E. Tcheng ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">St. Louis, MO</subfield><subfield code="b">Mosby</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2 S., S. 262 - 326</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">American heart journal</subfield><subfield code="v">138,4,2 = Suppl.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zeitschr.-Suppl.</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Thrombozytenmembran</subfield><subfield code="0">(DE-588)4416233-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ischämie</subfield><subfield code="0">(DE-588)4162456-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Thrombozytenaggregationshemmer</subfield><subfield code="0">(DE-588)4059968-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antigen CD41</subfield><subfield code="0">(DE-588)4604678-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herzkrankheit</subfield><subfield code="0">(DE-588)4024663-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">31.03.1998</subfield><subfield code="z">Atlanta, Ga.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Herzkrankheit</subfield><subfield code="0">(DE-588)4024663-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Ischämie</subfield><subfield code="0">(DE-588)4162456-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Thrombozytenaggregationshemmer</subfield><subfield code="0">(DE-588)4059968-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Thrombozytenmembran</subfield><subfield code="0">(DE-588)4416233-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Antigen CD41</subfield><subfield code="0">(DE-588)4604678-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tcheng, James E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008747739</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 31.03.1998 Atlanta, Ga. gnd-content |
| genre_facet | Konferenzschrift 31.03.1998 Atlanta, Ga. |
| id | DE-604.BV012856202 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:34:54Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008747739 |
| oclc_num | 45434919 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-12 |
| owner_facet | DE-19 DE-BY-UBM DE-12 |
| physical | 2 S., S. 262 - 326 Ill., graph. Darst. |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Mosby |
| record_format | marc |
| series2 | American heart journal |
| spelling | Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia guest ed.: James E. Tcheng ... St. Louis, MO Mosby 1999 2 S., S. 262 - 326 Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier American heart journal 138,4,2 = Suppl. Einzelaufnahme eines Zeitschr.-Suppl. Thrombozytenmembran (DE-588)4416233-9 gnd rswk-swf Ischämie (DE-588)4162456-7 gnd rswk-swf Thrombozytenaggregationshemmer (DE-588)4059968-1 gnd rswk-swf Antigen CD41 (DE-588)4604678-1 gnd rswk-swf Herzkrankheit (DE-588)4024663-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 31.03.1998 Atlanta, Ga. gnd-content Herzkrankheit (DE-588)4024663-2 s Ischämie (DE-588)4162456-7 s Thrombozytenaggregationshemmer (DE-588)4059968-1 s Thrombozytenmembran (DE-588)4416233-9 s Antigen CD41 (DE-588)4604678-1 s DE-604 Tcheng, James E. Sonstige oth |
| spellingShingle | Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia Thrombozytenmembran (DE-588)4416233-9 gnd Ischämie (DE-588)4162456-7 gnd Thrombozytenaggregationshemmer (DE-588)4059968-1 gnd Antigen CD41 (DE-588)4604678-1 gnd Herzkrankheit (DE-588)4024663-2 gnd |
| subject_GND | (DE-588)4416233-9 (DE-588)4162456-7 (DE-588)4059968-1 (DE-588)4604678-1 (DE-588)4024663-2 (DE-588)1071861417 |
| title | Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia |
| title_auth | Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia |
| title_exact_search | Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia |
| title_full | Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia guest ed.: James E. Tcheng ... |
| title_fullStr | Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia guest ed.: James E. Tcheng ... |
| title_full_unstemmed | Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia guest ed.: James E. Tcheng ... |
| title_short | Safety issues concerning the use of glycoprotein IIb - IIIa inhibitors in the management of acute coronary syndromes |
| title_sort | safety issues concerning the use of glycoprotein iib iiia inhibitors in the management of acute coronary syndromes proceedings of a roundtable meeting march 31 1998 atlanta georgia |
| title_sub | proceedings of a roundtable meeting, March 31, 1998, Atlanta, Georgia |
| topic | Thrombozytenmembran (DE-588)4416233-9 gnd Ischämie (DE-588)4162456-7 gnd Thrombozytenaggregationshemmer (DE-588)4059968-1 gnd Antigen CD41 (DE-588)4604678-1 gnd Herzkrankheit (DE-588)4024663-2 gnd |
| topic_facet | Thrombozytenmembran Ischämie Thrombozytenaggregationshemmer Antigen CD41 Herzkrankheit Konferenzschrift 31.03.1998 Atlanta, Ga. |
| work_keys_str_mv | AT tchengjamese safetyissuesconcerningtheuseofglycoproteiniibiiiainhibitorsinthemanagementofacutecoronarysyndromesproceedingsofaroundtablemeetingmarch311998atlantageorgia |